185 related articles for article (PubMed ID: 24245111)
1. PLGA nanoparticles as delivery systems for protoporphyrin IX in topical PDT: cutaneous penetration of photosensitizer observed by fluorescence microscopy.
da Silva CL; Del Ciampo JO; Rossetti FC; Bentley MV; Pierre MB
J Nanosci Nanotechnol; 2013 Oct; 13(10):6533-40. PubMed ID: 24245111
[TBL] [Abstract][Full Text] [Related]
2. Improved in vitro and in vivo cutaneous delivery of protoporphyrin IX from PLGA-based nanoparticles.
da Silva CL; Del Ciampo JO; Rossetti FC; Bentley MV; Pierre MB
Photochem Photobiol; 2013; 89(5):1176-84. PubMed ID: 23800045
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles.
Shi L; Wang X; Zhao F; Luan H; Tu Q; Huang Z; Wang H; Wang H
Int J Nanomedicine; 2013; 8():2669-76. PubMed ID: 23926429
[TBL] [Abstract][Full Text] [Related]
4. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers.
Rossetti FC; Depieri LV; Praça FG; Del Ciampo JO; Fantini MC; Pierre MB; Tedesco AC; Bentley MV
Eur J Pharm Sci; 2016 Feb; 83():99-108. PubMed ID: 26657201
[TBL] [Abstract][Full Text] [Related]
5. Treating cutaneous squamous cell carcinoma using 5-aminolevulinic acid polylactic-co-glycolic acid nanoparticle-mediated photodynamic therapy in a mouse model.
Wang X; Shi L; Tu Q; Wang H; Zhang H; Wang P; Zhang L; Huang Z; Zhao F; Luan H; Wang X
Int J Nanomedicine; 2015; 10():347-55. PubMed ID: 25609949
[TBL] [Abstract][Full Text] [Related]
6. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.
van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ
Photochem Photobiol; 2000 Sep; 72(3):399-406. PubMed ID: 10989612
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use.
Ricci-Júnior E; Marchetti JM
J Microencapsul; 2006 Aug; 23(5):523-38. PubMed ID: 16980274
[TBL] [Abstract][Full Text] [Related]
8. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
9. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
[TBL] [Abstract][Full Text] [Related]
10. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
[TBL] [Abstract][Full Text] [Related]
11. Microneedle-mediated intradermal nanoparticle delivery: Potential for enhanced local administration of hydrophobic pre-formed photosensitisers.
Donnelly RF; Morrow DI; Fay F; Scott CJ; Abdelghany S; Singh RR; Garland MJ; Woolfson AD
Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):222-31. PubMed ID: 21112544
[TBL] [Abstract][Full Text] [Related]
12. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
13. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
14. A quantitative study of in vivo protoporphyrin IX fluorescence build up during occlusive treatment phases.
Campbell CL; Brown CTA; Wood K; Salvio AG; Inada NM; Bagnato VS; Moseley H
Photodiagnosis Photodyn Ther; 2017 Jun; 18():204-207. PubMed ID: 28257944
[TBL] [Abstract][Full Text] [Related]
15. Protoporphyrin IX (PpIX) loaded PLGA nanoparticles for topical Photodynamic Therapy of melanoma cells.
da Silva DB; da Silva CL; Davanzo NN; da Silva Souza R; Correa RJ; Tedesco AC; Riemma Pierre MB
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102317. PubMed ID: 33940210
[TBL] [Abstract][Full Text] [Related]
16. Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin.
van den Akker JT; Boot K; Vernon DI; Brown SB; Groenendijk L; van Rhoon GC; Sterenborg HJ
Photochem Photobiol Sci; 2004 Mar; 3(3):263-7. PubMed ID: 14993942
[TBL] [Abstract][Full Text] [Related]
17. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
18. Protoporphyrin IX-loaded magnetoliposomes as a potential drug delivery system for photodynamic therapy: Fabrication, characterization and in vitro study.
Basoglu H; Bilgin MD; Demir MM
Photodiagnosis Photodyn Ther; 2016 Mar; 13():81-90. PubMed ID: 26751701
[TBL] [Abstract][Full Text] [Related]
19. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
20. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.
Forster B; Klein A; Szeimies RM; Maisch T
Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
